[
    [
        {
            "time": "2021-12-07",
            "original_text": "天坛生物：“人凝血酶原复合物”获得临床试验总结报告",
            "features": {
                "keywords": [
                    "天坛生物",
                    "人凝血酶原复合物",
                    "临床试验",
                    "总结报告"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "天坛生物：“人凝血酶原复合物”获得临床试验总结报告",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-07",
            "original_text": "天坛生物(600161.SH)所属“人凝血酶原复合物”完成临床试验并取得总结报告",
            "features": {
                "keywords": [
                    "天坛生物",
                    "600161.SH",
                    "人凝血酶原复合物",
                    "临床试验",
                    "总结报告"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "天坛生物(600161.SH)所属“人凝血酶原复合物”完成临床试验并取得总结报告",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-07",
            "original_text": "天坛生物(600161.SH)：兰州血制研制的“人凝血酶原复合物”完成了临床试验并取得临床试验总结报告",
            "features": {
                "keywords": [
                    "天坛生物",
                    "600161.SH",
                    "兰州血制",
                    "人凝血酶原复合物",
                    "临床试验",
                    "总结报告"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "天坛生物(600161.SH)：兰州血制研制的“人凝血酶原复合物”完成了临床试验并取得临床试验总结报告",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022",
            "original_text": "深度分析！十张图带您了解2022年血液制品市场企业下一个争夺点在哪里？",
            "features": {
                "keywords": [
                    "血液制品市场",
                    "企业争夺点",
                    "2022年"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "市场分析"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "深度分析！十张图带您了解2022年血液制品市场企业下一个争夺点在哪里？",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        }
    ]
]